M. Boos

发表

Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.

K. Köhrer, J. Verhoef, A. Fluit, 2000, The Journal of antimicrobial chemotherapy.

Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus.

F. Schmitz, A. Fluit, A. Beyer, 2001, The Journal of antimicrobial chemotherapy.

Development of Resistance to Ciprofloxacin, Rifampin, and Mupirocin in Methicillin-Susceptible and -ResistantStaphylococcus aureus Isolates

K. Köhrer, J. Verhoef, A. Fluit, 2000, Antimicrobial Agents and Chemotherapy.

Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae.

F. Schmitz, A. Fluit, D. Hafner, 2001, The Journal of antimicrobial chemotherapy.

Propensity of Fluoroquinolones with Different Moieties at Position 8 to Cause Resistance Development in Clinical Isolates of Streptococcus pneumoniae

J. Verhoef, F. Schmitz, A. Fluit, 2001, Antimicrobial Agents and Chemotherapy.

Production of BRO β-Lactamases and Resistance to Complement in European Moraxella catarrhalis Isolates

K. Köhrer, J. Verhoef, A. Fluit, 2002, Journal of Clinical Microbiology.

In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

K. Köhrer, J. Verhoef, P. Heisig, 2001, Antimicrobial Agents and Chemotherapy.

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).

P. Pumpens, Stefan Ross, V. Ose, 2006, Vaccine.

Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity.

P. Pumpens, M. Mihailova, S. Viazov, 2006, Protein expression and purification.

In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.

F. Schmitz, A. Fluit, D. Milatovic, 2002, The Journal of antimicrobial chemotherapy.

In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.

J. Verhoef, F. Schmitz, A. Fluit, 2002, The Journal of antimicrobial chemotherapy.

In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.

J. Verhoef, F. Schmitz, A. Fluit, 2001, The Journal of antimicrobial chemotherapy.

Quinolone-Resistance Mechanisms and In Vitro Susceptibility Patterns Among European Isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae

F. Schmitz, A. Fluit, D. Milatovic, 2001, European Journal of Clinical Microbiology and Infectious Diseases.